SCHEMBL30737301

SCHEMBL30737301

C#CCOCCOCCOC1CN(CCOCCOc2cccc(Oc3ccc(C(=O)OC)cn3)c2)C1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.38
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
SORT1 Q99523 1/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
OPRM1 P35372 3/20 0.34
OPRD1 P41143 3/20 0.34
OPRK1 P41145 1/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
HPGDS O60760 1/20 0.34
LIPE Q05469 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30737459 0.90 KDM4E (0.44) HRH3KDM4EALDH1A1KMT2AGAA
SCHEMBL30737508 0.88 MAPT (0.43) HRH3KDM4EALDH1A1MEN1KMT2A
SCHEMBL30737281 0.80 HRH3 (0.36) HRH3KMT2ALMNALIPE
SCHEMBL30737347 0.78 PRKAA2 (0.42) HRH3KMT2AMAPT
SCHEMBL30737465 0.76 MAPT (0.45) KDM4EALDH1A1MEN1KMT2ASORT1
SCHEMBL30737488 0.76 MAPT (0.45) KDM4EALDH1A1MEN1KMT2ASORT1
SCHEMBL30737383 0.76 MAPT (0.45) KDM4EALDH1A1MEN1KMT2ASORT1
SCHEMBL31646216 0.74 MAPT (0.50) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL30737156 0.73 MAPT (0.44) HRH3KDM4EALDH1A1MEN1KMT2A
SCHEMBL31724770 0.70 BCHE (0.44) KDM4EALDH1A1SORT1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2025-11-13 US disclosed
EP-4543858-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES Draupnir Bio ApS (DK) 2025-04-30 EP disclosed
WO-2023247754-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES SORT1, SCARB1, LAMP1 HRH3 2954/4885KDM4E 4709/4885ALDH1A1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.